Delivery Order SPE2DR25D2104-SPE2DR26F3RUV
- Not listed
- The Defense Logistics Agency awarded a $7,157.24 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Gralise ER 300 mg tablets (90-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Gralise ER 600 mg tablets (90-count) with a ceiling value of $3,305.61. The delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical, is scheduled for completion by December 16, 2025. This non-set-aside award was made competitively through the federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,234.56 firm fixed-price contract provides the GRALISE ER 600 MG TABLET 90S pharmaceutical product, with a completion date of November 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is a $2,599.99 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is the prime contractor providing GRALISE ER 600 MG TABLET 90S to support military treatment programs and facilities. The contract has a completion date of February 13,...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- This is a $14,845.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The delivery order has a completion date of January 12, 2024 and was awarded on January 11, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gralise ER 600 mg tablets, with a ceiling value of $4,011.50 and a period of performance through June 27, 2025. The contract is not set-aside and involves the supply of pharmaceutical products to support military and government healthcare programs....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $2,630.61 and is for the delivery of the pharmaceutical product Gralise ER 300 mg Tablet 90s. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for providing this medication and other pharmaceutical and medical supplies to support military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $8,438.84 order is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The delivery order has a performance location of Conshohocken, Pennsylvania and a completion date of January 10, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is an established prime contractor...
- This is a $8,879.52 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3RUVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of GRALISE ER 300 mg tablets (90-count packages) with a contract value of $1,479.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the company's capability to compete in open federal procurement processes. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. The DLA Troop Support Medical supply chain leverages this vehicle to meet the pharmaceutical procurement needs of the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/16/25 |